Home › Hypertrophic Cardiomyopathy
Pag-aaral pangklinika para sa Hypertrophic Cardiomyopathy na nagre-recruit sa U.S.
17 pag-aaral para sa Hypertrophic Cardiomyopathy ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Boston, MA6 pag-aaral
- San Francisco, CA4 pag-aaral
- Charlottesville, VA4 pag-aaral
- Cleveland, OH4 pag-aaral
- San Diego, CA3 pag-aaral
- Houston, TX3 pag-aaral
- Charlotte, NC3 pag-aaral
- Chicago, IL3 pag-aaral
- Plano, TX3 pag-aaral
- New York City, NY3 pag-aaral
Ayos sa estado
- California7 pag-aaral
- Illinois4 pag-aaral
- Massachusetts6 pag-aaral
- Michigan3 pag-aaral
- Minnesota3 pag-aaral
- Missouri3 pag-aaral
- New York5 pag-aaral
- North Carolina3 pag-aaral
- Ohio4 pag-aaral
- Pennsylvania3 pag-aaral
- Texas4 pag-aaral
- Virginia4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Nagre-recruitPhase 3
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07755904Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
Nagre-recruitPhase 2
Edad 6 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07721025A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05489705Study of the Progression of Chronic Cardiovascular Conditions
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT07420907Cardiovascular Multimodality Imaging Study
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06610019Pediatric Cardiomyopathy Mutation Analysis
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT02432092Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 50 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT06034405Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy
Nagre-recruitPhase 4
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update May 20, 2026 · NCT07600177A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT07023614A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
Nagre-recruitPhase 2
Edad 8 pataas · Kalalakihan · Na-update May 4, 2026 · NCT06092034Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
Nagre-recruitPhase 1/2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 19, 2026 · NCT05836259HCMR Re-Imaging Study
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT07054073Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy
Nagre-recruit
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 20, 2025 · NCT05818605Mavacamten Pregnancy Surveillance Program
Nagre-recruitObservasyonal na pag-aaral
Edad 15 pataas · Kababaihan · Na-update Nob 6, 2025 · NCT05939700Large Language Models To Improve the Quality of Care of Cardiology Patients
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2025 · NCT06935253Real-world Patient Reported Outcomes Among Patients Treated With Camzyos
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 7, 2024 · NCT06551129Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Nob 6, 2024 · NCT06023186Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.